Prenetics Global Limited (PRE)
| Market Cap | 174.63M -12.0% |
| Revenue (ttm) | 199.14M +158.4% |
| Net Income | -65.00M |
| EPS | -3.84 |
| Shares Out | 16.94M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 821,098 |
| Open | 10.32 |
| Previous Close | 10.35 |
| Day's Range | 9.69 - 11.79 |
| 52-Week Range | 9.13 - 27.24 |
| Beta | 0.40 |
| Analysts | Strong Buy |
| Price Target | 36.22 (+251.31%) |
| Earnings Date | Nov 18, 2026 |
About PRE
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Financial Performance
In 2025, Prenetics Global's revenue was $92.39 million, an increase of 479.76% compared to the previous year's $15.94 million. Losses were -$37.71 million, -18.56% less than in 2024.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for PRE stock is "Strong Buy." The 12-month stock price target is $36.22, which is an increase of 251.31% from the latest price.
News
Prenetics price target lowered to $30 from $36 at Roth Capital
Roth Capital lowered the firm’s price target on Prenetics (PRE) to $30 from $36 and keeps a Buy rating on the shares. The stock traded down materially following its Q3…
Prenetics price target lowered to $31 from $37 at B. Riley
B. Riley lowered the firm’s price target on Prenetics (PRE) to $31 from $37 and keeps a Buy rating on the shares. Prenetics beat revenue expectations on rapid IM8 growth…
Lake Street says Prenetics selloff overdone
Lake Street noted that the 40% selloff in Prenetics (PRE) shares following “solid” Q3 results is overdone and presents an attractive buying opportunity. The firm told investors that while the…
Prenetics Global Ltd trading resumes
09:41 EST Prenetics (PRE) Global Ltd trading resumes
Prenetics Global Ltd trading halted, volatility trading pause
09:31 EST Prenetics (PRE) Global Ltd trading halted, volatility trading pause
Prenetics Global Earnings Call Transcript: Q3 2026
Q3 revenue reached $64.1M, while adjusted free cash flow was positive with General Catalyst funding. Growth investment raised the H2 adjusted EBITDA loss outlook, alongside reaffirmed FY2027 revenue guidance of at least $400M for current products.
Prenetics Global Earnings release: Q3 2026
Prenetics Global released its Q3 2026 earnings on November 18, 2026, summarizing the period's financial results.
Prenetics Global Slides: Q3 2026
Prenetics Global has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 18, 2026.
Prenetics Global Shareholder letter: Q3 2026
Prenetics Global has published a letter to shareholders covering Q3 2026, which was released on November 18, 2026.
Prenetics' IM8 Reports Q3 2026 Revenue Growth of 266% YoY; Earliest Customers Have Returned More Than 3x Their Acquisition Cost in Under Two Years; Reaffirms FY 2026 Total Revenue Guidance of $220–230 Million and FY 2027 IM8 Revenue Guidance of $400 Million+
— Total revenue of $64.1 million, up ~228% YoY (~3.3x); above the Company's guidance of $63–64 million — IM8 revenue of $62.9 million, up ~266% YoY (~3.7x); above the Company's guidance of $61.5–62.5 ...
Prenetics' IM8 Announces Three-Time GRAMMY-Winning DJ and Producer Diplo as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
— Diplo is IM8's first Global Ambassador from music and takes a roster built in elite sport onto the world's biggest stages — Diplo brings a social following of more than 12 million across Instagram, ...
Care Bears And Prenetics' IM8 Announce Global Partnership
IM8 family wellness brand to launch gummy multivitamins for kids and adults in 2027, marking Care Bears' 45th anniversary NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Care Bears, part of Authentic Brands Gr...
Prenetics' IM8 and Authentic Brands Group Announce 10-Year Exclusive Global Partnership to Create Care Bears by IM8; Authentic to Become Strategic Shareholder in Prenetics
Care Bears by IM8 to launch, with great-tasting, science-backed gummy multivitamins for kids and adults in 1H 2027 Enters a global gummy supplements market projected to nearly double to ~US$47.8 billi...
Prenetics' IM8 Names Brian J. Rosin as Successor Chief Financial Officer
- Completes planned leadership transition as Prenetics revenue is almost entirely IM8 - Prenetics' finance leadership function now based in the United States - The Company will report third quarter 20...
Prenetics falls after CFO Stephen Hoi Chun tenders resignation
Prenetics (PRE) is moving lower after the company this morning disclosed that Stephen Hoi Chun Lo tendered his resignation as Chief Financial Officer, effective December 30, to pursue new opportunitie...
Maxim starts Prenetics at Buy amid consumer interest in health and wellness
As previously reported, Maxim initiated coverage of Prenetics (PRE) with a Buy rating and $41 price target The company is well-positioned to capitalize on consumers’ increasing interest in health &…
Prenetics initiated with a Buy at Maxim
Maxim analyst Tom Forte initiated coverage of Prenetics (PRE) with a Buy rating and $41 price target
Prenetics initiated with a Buy at Titan Partners
Titan Partners analyst Kyle Bauser initiated coverage of Prenetics (PRE) with a Buy rating and $52 price target Prenetics is a consumer health company focused on its premium wellness brand,…
Prenetics initiated with a Buy at Lucid Capital
Lucid Capital initiated coverage of Prenetics (PRE) with a Buy rating and $54 price target The firm says prevention, wellness, and longevity is not a fad category. The sector “will…
Prenetics Global Registration statement: Registration filing
Prenetics Global filed a registration statement on September 22, 2026, providing details about a securities offering with the SEC.
Craig-Hallum bullish on Prenetics, initiates with a Buy
As previously reported, Craig-Hallum analyst Eric Des Lauriers initiated coverage of Prenetics (PRE) with a Buy rating and $40 price target Despite becoming the quickest supplement brand to reach $100...
Prenetics initiated with a Buy at Craig-Hallum
Craig-Hallum initiated coverage of Prenetics (PRE) with a Buy rating and $40 price target
Prenetics Global Registration statement: Registration filing
Prenetics Global filed a registration statement on September 8, 2026, providing details about a securities offering with the SEC.
Prenetics initiated with a Buy at B. Riley
B. Riley initiated coverage of Prenetics (PRE) with a Buy rating and $37 price target The firm says its investment thesis is predicated upon Prenetics becoming U.S.-domiciled. The company transformed…
Prenetics' IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
Cumulative Personal Investment by Leadership Since November 2025 Reaches Approximately $3.75 Million NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or ...